NorthWest Biotherapeutics Inc (NWBO)

[Poor Man -]

Each warrant will entitle the holder to purchase the securities that we specify in the applicable prospectus supplement at the exercise price that we describe in the applicable prospectus supplement. Unless we otherwise specify in the applicable prospectus supplement, holders of the warrants may exercise the warrants at any time up to 5:00 p.m. Eastern Time on the expiration date that we set forth in the applicable prospectus supplement. After the close of business on the expiration date, unexercised warrants will become void.

Very nicely played by Linda and Les..take back what I said about them yesterday. Could have released the same news two weeks ago, but waited unit one second after expiration of the 60 day warrants at 5:00pm - thereby saving us considerable dilution at a low ball price.

And, they were able to use the opportunity to soften the Nasdaq non-compliance, which appears readily resolvable, but could have nonetheless been damaging on its own given the recent downward trajectory of the stock.

My guess is there are probably some unflattering items in the investigative report (maybe this was it?) and they may be waiting for other good news before releasing the report in order to dampen the effect. It's hard to complete a full legal due diligence and not come up with anything.

Really good news today. Big Pharma is validating the platform technology, and I doubt they would enter into any agreements if FDA is having issues with L.